Stocks / NASDAQ / Autonomix Medical Inc.

Autonomix Medical Inc.

Our Opinion

Autonomix Medical Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following press release that it exploits animals for product testing.

“Based on the successful completion of the ablation animal safety study, the Company is advancing towards its first-in-human clinical study for the use of RF ablation in the reduction of pancreatic cancer pain, which is expected to commence enrollment in Q1 2024.” Read the following article

Company Description

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. It has an agreement with NoiseFigure Research, Inc. to develop next generation of its proprietary microchip. Autonomix Medical, Inc. was incorporated in 2014 and is based in The Woodlands, Texas.

Company Website: https://www.autonomix.com